FLAME 30
Antibiotics: Technologies and Global Markets
Report Highlights
The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%.
Report Includes
- An overview of the global market for systemic antibiotics.
- Analyses of global market trends, with data from 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Details on the factors most impacting the market, including major market growth inhibitors and catalysts.
- Discussion on important trends and products.
- Comprehensive profiles of leading companies in the industry.
SCOPE OF REPORT
This research report categorizes the systemic antibiotics market into the following segments:
Antibiotics market (human application) by product:
- Beta-lactams.
- Penicillin.
- Cephalosporins.
- Carbapenems.
- Fluoroquinolones.
- Second generation.
- Third generation.
- Others.
- Macrolides.
- Tetracycline.
- Other antibiotic classes.
Antibiotics market by application:
- Human applications.
- Veterinary applications.
ANALYST CREDENTIALS
Neha Maliwal, a graduate in biotechnology and a postgraduate in marketing and biotechnology from the University of Pune (India), is the author this study and numerous others, including the analyses of related markets such as radiopharmaceuticals, healthcare business process outsourcing (BPO) and biotechnology instrumentation.
A special mention goes to Silva Quattrocchi, who has a master’s degree in molecular biotechnology from the University of Bologna (Italy), for her input on the antibiotics market.
Report Highlights
- Overall sales in the current antibiotics and new products market were nearly $40 billion in 2008. It increased to $41.5 billion in 2009. By 2014, it is projected to increase to $65.5 billion, for a 5-year compound annual growth rate (CAGR) of 9.6%.
- The largest segment antibiotic drugs market was nearly $36 billion in 2008; this further increased to $37 billion in 2009, this projected to reach $50 billion in 2014, for a 5-year CAGR of 5.9%.
- Sales in the bacterial vaccines market amounted to $3.6 billion in 2008 which increased slightly to $3.9 billion in 2009. This is projected to increase to $15 billion in 2014, for a 5-year CAGR of 31.6%.
Report Highlights
- Worldwide, the total market for new and currently available antibiotics reached $22.3 billion in 2001. Average annual growth rate (AAGR) of 9.1%, this market will climb to $34.5 billion in 2006.
- Growth will be driven by new products, whose sales will rise at an AAGR of more than 50% to $7.4 billion in 2006, representing 21% of the total market.
- Sales in 2001 were just under $1 billion, just 4% of the market.
- In 2001, the market for currently available antibiotics was $21.3 billion and is projected to increase at an AAGR of only 4.9% to $27.2 billion by 2006.
- From 2001 to 2006, some 40 new products or formulations could be introduced into the antibiotics sector.
- Many of these drugs will likely prove effective against infectious disease organisms that have developed multidrug resistances, rejuvenating the antibiotics market.
